| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/01/2005 | EP1534282A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 06/01/2005 | EP1534269A1 Oxime conjugates and methods for their formation and use |
| 06/01/2005 | EP1534261A2 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 06/01/2005 | EP1534252A2 Breath freshening and oral cleansing product using cardamom oil |
| 06/01/2005 | EP1534251A1 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
| 06/01/2005 | EP1534250A2 Electrospun amorphous pharmaceutical compositions |
| 06/01/2005 | EP1534249A1 Chewable soft capsule |
| 06/01/2005 | EP1534248A1 Lasofoxifene tablet and its coating |
| 06/01/2005 | EP1534246A1 Sustained release pharmaceutical composition of a cephalosporin antibiotic |
| 06/01/2005 | EP1534245A1 Rapidly disintegrating tablet |
| 06/01/2005 | EP1534241A1 Transdermal aerosol compositions |
| 06/01/2005 | EP1534238A1 Formulations and dosage forms for controlled delivery of topiramate |
| 06/01/2005 | EP1534237A1 Orally disintegrating tablets and process for obtaining them. |
| 06/01/2005 | EP1534236A1 Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
| 06/01/2005 | EP1534229A2 Branched alcohol-based personal care compositions |
| 06/01/2005 | EP1534213A2 Water-based delivery systems |
| 06/01/2005 | EP1534072A2 Anthelmintic oral homogeneous veterinary pastes |
| 06/01/2005 | EP1534070A2 Methods for treating fungal infections |
| 06/01/2005 | EP1453781B1 Method for the production of alpha- mannite directly compressible into tablets |
| 06/01/2005 | EP1411926B1 Integrin inhibitors for the treatment of eye diseases |
| 06/01/2005 | EP1395231B1 Preparation for the removal of abnormal keratin material |
| 06/01/2005 | EP1383539A4 Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
| 06/01/2005 | EP1347760B1 Nmda receptor agonist pharmaceutical compositions |
| 06/01/2005 | EP1265614B1 Novel galenical form for oral administration with prolonged release of molsidomine |
| 06/01/2005 | EP1254179A4 An in vivo screen using chemical inducers of dimerization |
| 06/01/2005 | EP1206189B1 Rotavirus vaccine formulations |
| 06/01/2005 | EP1173205B1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
| 06/01/2005 | EP1148871B1 Core tablet for controlled release of gliclazide after oral administration |
| 06/01/2005 | EP1143927B1 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants |
| 06/01/2005 | EP0954573B1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 06/01/2005 | CN1622986A Pressure-sensitive adhesive and patch employing the same |
| 06/01/2005 | CN1622835A Process for production of pressure-sensitive adhesive moldings comprising crosslinked polymers as the main component |
| 06/01/2005 | CN1622832A Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 06/01/2005 | CN1622831A Method of promoting nucleic acid transfer |
| 06/01/2005 | CN1622830A Peptide-based compounds |
| 06/01/2005 | CN1622827A Thrombin derived peptides for promoting cardiac tissue repair |
| 06/01/2005 | CN1622826A Stimulation of bone growth and cartilage formation with thrombing peptide derivatives |
| 06/01/2005 | CN1622822A Medicinal compositions containing ghrelin |
| 06/01/2005 | CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound |
| 06/01/2005 | CN1622810A 孕酮口服药物传输系统 Progesterone oral drug delivery system |
| 06/01/2005 | CN1622809A Orodispersible pharmaceutical composition comprising ivabradine |
| 06/01/2005 | CN1622804A Orodispersible pharmaceutical composition of agomelatine |
| 06/01/2005 | CN1622802A Composition for inhalation |
| 06/01/2005 | CN1622800A 可食用pga涂层组合物 Edible coating composition pga |
| 06/01/2005 | CN1622754A Novel immune effect compound |
| 06/01/2005 | CN1621093A Construction of 5-fluorouracil chitosan minipill for filling to inside of the bladder to treat bladder cancer |
| 06/01/2005 | CN1621092A Folic acid receptor targeted liposome medicine carrier, its preparation and application |
| 06/01/2005 | CN1621091A Intestine targeted formulation of PEGylated rotavirus and its synthesizing method |
| 06/01/2005 | CN1621031A Composition and preparation method of soft capsule shell colloid emulsion |
| 06/01/2005 | CN1621030A Oral solid preparation of water indissoluble medicine and/or acid sensitive medicinal composition |
| 06/01/2005 | CN1204020C Terminally sterilized topical patch preparation and production methods thereof |
| 06/01/2005 | CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy |
| 06/01/2005 | CN1203897C Sustained release salts of pharmaceutically active peptides and production thereof |
| 06/01/2005 | CN1203896C Low substituted ethylene-lactic cellulose and solid preparation |
| 06/01/2005 | CN1203895C Topical compositions containing prostaglandin E1 |
| 06/01/2005 | CN1203892C Aqueous solution formulation of alpha-interferon |
| 06/01/2005 | CN1203862C Compound glucose injection with clindamycin and metronidazole |
| 06/01/2005 | CN1203855C Pharmaceutical solutions for levosimendan |
| 06/01/2005 | CN1203854C Compositions having improved delivery of actives |
| 06/01/2005 | CN1203852C Valdecoxib compositions |
| 06/01/2005 | CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof |
| 06/01/2005 | CN1203844C Solid themoformable pharmaceutical composition for the controlled release of ivabradine |
| 06/01/2005 | CN1203842C Arificial tear solution |
| 05/31/2005 | US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 05/31/2005 | US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/31/2005 | US6900301 Oligonucleotides for use in human therapeutics an diagnostics |
| 05/31/2005 | US6900297 A compound which hybridizes with a nucleic acid includes multiple inked nucleosides (inlcudes a pentofuranosyl sugar portion and a base portion), and at least one sugar o-is terminated with R-N(R1a R1b) substitutent |
| 05/31/2005 | US6900192 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 05/31/2005 | US6900184 Synergistic mixture of piperacillin and tazobactam; controlling bacteria infections |
| 05/31/2005 | US6900055 Oxygen permeable biocompatible elastomer for propagating viable tissue; tissue engineering |
| 05/31/2005 | US6899901 Cooling or heating sensitizers such as oleoresin or spilanthol, for use in foods, drugs or cosmetics |
| 05/31/2005 | US6899898 Induced phase transition method for the production of microparticles containing hydrophobic active agents |
| 05/31/2005 | US6899897 Comprises benzoin gum, fungicidal clotrimazole, and ethanol; for treatment of athelete's foot, eczema, seborrheic dermatitis and psoriasis |
| 05/31/2005 | US6899896 Hydrogel-driven layered drug dosage form |
| 05/31/2005 | US6899895 Complexes |
| 05/31/2005 | US6899894 Mixture of oestradiol and norethisterone acetate applied to backing with pressure sensitive adhesive; protective coatings; multilayer |
| 05/31/2005 | US6899890 Bioadhesive drug delivery system |
| 05/31/2005 | US6899889 Biocompatible material composition adaptable to diverse therapeutic indications |
| 05/31/2005 | US6899868 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 05/31/2005 | US6899867 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 05/31/2005 | US6899864 Kit and method for targeting of a diagnostic or therapeutic agent to target site in mammal having a pathological condition |
| 05/31/2005 | US6899723 Transcutaneous photodynamic treatment of targeted cells |
| 05/31/2005 | CA2127352C Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it |
| 05/26/2005 | WO2005047337A1 A pharmaceutical composition comprising an immunoglobulin fc region as a carrier |
| 05/26/2005 | WO2005047336A1 Protein complex using immunoglobulin fragment andmethod for the preparation thereof |
| 05/26/2005 | WO2005047335A1 Method for themass production of immunoglobulin constant region |
| 05/26/2005 | WO2005047334A1 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 05/26/2005 | WO2005047231A1 Non-symmetrical gelling agent |
| 05/26/2005 | WO2005046735A1 A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes |
| 05/26/2005 | WO2005046730A2 Biotin-facilitated transport into gram negative bacteria |
| 05/26/2005 | WO2005046729A2 Use of lipopeptides for activating t lymphocytes through the skin |
| 05/26/2005 | WO2005046728A1 Polysaccharide-containing composition and tear film stabilizing ophthalmic solution |
| 05/26/2005 | WO2005046722A2 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer |
| 05/26/2005 | WO2005046715A1 Physiologically active complex |
| 05/26/2005 | WO2005046699A1 Freeze-dried article containing prostaglandin |
| 05/26/2005 | WO2005046680A1 Percutaneous absorption type cerebral protective agent |
| 05/26/2005 | WO2005046663A1 Compositions of quaternary ammonium containing bioavailability enhancers |
| 05/26/2005 | WO2005046651A1 Liquid filled capsules of doxycycline |
| 05/26/2005 | WO2005046641A2 Compositions and methods for treating a posterior segment of an eye |
| 05/26/2005 | WO2005046637A2 Pharmaceutical formulations employing short-chain sphingolipids and their use |